Risk-Based Approach To Clinical AE Reporting Needed – Medtronic’s Westrum
This article was originally published in The Gray Sheet
Executive Summary
Clinical trial sponsors are limited in their ability to facilitate compliance with institutional review boards, even though investigators often lack thorough grounding in IRB policies, according to Medtronic Director of Clinical Affairs Barbara Westrum